- Home
- LMFA vs PMCB Comparison
LMFA vs PMCB Comparison
Compare LMFA & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- PMCB
- Stock Information
- Founded
- LMFA 2008
- PMCB 1996
- Country
- LMFA United States
- PMCB United States
- Employees
- LMFA N/A
- PMCB N/A
- Industry
- LMFA Finance: Consumer Services
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LMFA Finance
- PMCB Health Care
- Exchange
- LMFA Nasdaq
- PMCB Nasdaq
- Market Cap
- LMFA 8.6M
- PMCB 7.6M
- IPO Year
- LMFA 2015
- PMCB N/A
- Fundamental
- Price
- LMFA $2.36
- PMCB $1.05
- Analyst Decision
- LMFA Hold
- PMCB
- Analyst Count
- LMFA 1
- PMCB 0
- Target Price
- LMFA N/A
- PMCB N/A
- AVG Volume (30 Days)
- LMFA 104.2K
- PMCB 8.5K
- Earning Date
- LMFA 08-13-2025
- PMCB 08-12-2025
- Dividend Yield
- LMFA N/A
- PMCB N/A
- EPS Growth
- LMFA N/A
- PMCB N/A
- EPS
- LMFA N/A
- PMCB 1.29
- Revenue
- LMFA $8,029,601.00
- PMCB N/A
- Revenue This Year
- LMFA $0.98
- PMCB N/A
- Revenue Next Year
- LMFA $4.31
- PMCB N/A
- P/E Ratio
- LMFA N/A
- PMCB $0.81
- Revenue Growth
- LMFA N/A
- PMCB N/A
- 52 Week Low
- LMFA $1.02
- PMCB $1.00
- 52 Week High
- LMFA $5.35
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- LMFA 67.15
- PMCB 47.26
- Support Level
- LMFA $1.62
- PMCB $1.00
- Resistance Level
- LMFA $2.46
- PMCB $1.07
- Average True Range (ATR)
- LMFA 0.18
- PMCB 0.05
- MACD
- LMFA 0.05
- PMCB 0.01
- Stochastic Oscillator
- LMFA 82.74
- PMCB 39.78
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.